Search

Your search keyword '"Jenabian, Mohammad-Ali"' showing total 447 results

Search Constraints

Start Over You searched for: Author "Jenabian, Mohammad-Ali" Remove constraint Author: "Jenabian, Mohammad-Ali"
447 results on '"Jenabian, Mohammad-Ali"'

Search Results

5. Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study

8. Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART

9. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

10. Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)

12. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

13. Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028.

14. New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy

15. IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV.

18. Donating One’s Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study

20. Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaques

22. Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

24. Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV.

25. Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study

28. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

31. Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

32. COVID-19 vaccine immunogenicity in people with HIV

33. Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study

40. Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral Therapy.

42. High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study

46. COVID-19 vaccine immunogenicity in people with HIV.

47. Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

49. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

Catalog

Books, media, physical & digital resources